Journal List > J Korean Diabetes Assoc > v.31(6) > 1062478

Choi, Min, Kim, Koo, Lim, Kim, Pak, Han, and Kim: Relationship between Endothelial-dependent/-independent Vasodilation and Carotid Intimal-media Thickness in Newly-diagnosed Korean Type 2 Diabetic Patients

Abstract

Background

The relative effect of diabetes on the risk of cardiovascular disease in Asian population is much the same as that in Western populations. Although multiple atherosclerotic risk factors have been documented in Asia, precise estimates of vascular reactivity might provide more critical informations for the prevention and the control of diabetes-related cardiovascular mortality and morbidity. The aims of this study were to estimate the vascular reactivity directly and evaluate its relationship with other cardiovascular risk factors and carotid intimal-media thickness (IMT) in newly-diagnosed Korean type 2 diabetic patients.

Methods

We measured flow-mediated vasodilation (FMD) and endothelial-independent vasodilation (EID) of the brachial artery using high-resolution ultrasonography in total of 121 (M; N = 68, F; N = 53) diabetic patients. We assessed conventional cardiovascular risk factors such as age, smoking, obesity, hypertension, hyperlipidemia or family history of cardiovascular disease and analyzed the association among FMD/EID with cardiovascular risk factors, carotid IMT or the total number of risk factors.

Results

The mean values of age, smoking, BMI, waist, systolic blood pressure and diastolic blood pressure were 51.2 ± 12.3 years, 11.0 ± 15.8 pack years, 25.0 ± 3.2 kg/m2, 86 ± 9 cm, 123 ± 16 mmHg and 79 ± 12 mmHg. The mean values of HbA1c, fasting blood glucose, total cholesterol, triglyceride, LDL-cholesterol and HDL-cholesterol were 8.4 ± 2.0%, 166 ± 51 mg/dL, 187 ± 37 mg/dL, 166 ± 143 mg/dL, 114 ± 30 mg/dL and 46 ± 12 mg/dL. FMD and EID were estimated by 6.1 ± 2.8% and 16.6 ± 5.6% respectively. The mean/maximal carotid IMT were 0.63 ± 0.12/0.76 ± 0.16 mm and the number of risk factors besides diabetes mellitus were 2.3 ± 1.3. After adjusting age, FMD was associated only with smoking, but EID was associated with smoking, systolic/diastolic blood pressure, mean/maximal carotid IMT and number of risk factors by partial correlations. Age, smoking and EID were independent risk variables for carotid IMT, analyzed by multiple regression test.

Conclusion

These findings suggest that impaired vascular reactivity detected by EID is closely related to carotid IMT, an useful surrogate marker for atherosclerosis, in newly-diagnosed Korean type 2 diabetic patients.

Figures and Tables

Fig. 1
Prevalence of risk factors besides diabetes (A) and incidence of patients who had CVD risk factors (B).
jkda-31-498-g001
Fig. 2
Correlations between endothelium-independent vasodilation (EID) and mean carotid IMT (A) or number of CVD risk factors besides diabetes (B).
jkda-31-498-g002
Table 1
Clinical characteristics of 121 newly diagnosed diabetic patients
jkda-31-498-i001

BMI, body mass index; FPG, fasting plasma glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; FMD, flow-mediated vasodilation; EID, endothelium-independent vasodilation; IMT, carotid intimal-media thickness.

Table 2
Correlations among clinical variables with FMD or EID
jkda-31-498-i002

Ln_Triglyceride, Triglyceride transformed by log-scale. *P < 0.05. P < 0.01. P < 0.001. Analyzed by Pearsons' correlation test (r) and partial correlations [age-controlled(r)].

Table 3
Multiple regression analysis for mean carotid IMT as dependent variables
jkda-31-498-i003

Dependent variable: mean carotid IMT, r2 = 0.43 P < 0.001, Ln_Triglyceride, Triglyceride transformed by log-scale.

References

1. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979. 59:8–13.
2. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death; a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med. 2004. 164:1422–1426.
3. de Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart JC, Kastelein JJ. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation. 2004. 109:33–38.
4. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999. 340:14–22.
5. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992. 340:1111–1115.
6. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995. 26:1235–1241.
7. Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D, Bauer P, Weidinger F. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis. 1997. 129:111–118.
8. Zhang Xiang-yu, Zhao Shui-ping, Li Xiang-ping, Gao Mei, Zhou Qi-Chang. Endothelium-dependent and -independent functions are impaired in patients with coronary heart disease. Atherosclerosis. 2000. 149:19–24.
9. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, Celermajer DS. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol. 1998. 32:123–127.
10. Jarvisalo M, Lehtimaki T, Raitakari OT. Determinants of arterial nitrate-mediated dilation in children; Role of low-density lipoprotein, endothelial function, and carotid intima-media thickness. Circulation. 2004. 109:2885–2889.
11. Raitakari OT, Seale JP, Celermajer DS. Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis. Am J Cardiol. 2001. 87:217–219.
12. Vita JA, Keaney JF Jr. Endothelial function; a barometer for cardiovascular risk? Circulation. 2002. 106:640–642.
15. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002. 39:257–265.
17. Komatsu M, Kawagishi T, Emoto M, Shoji T, Yamada A, Sato K, Hosoi M, Nishizawa Y. eNOS gene polymorphism is associated with endothelium-dependent vasodilation in Type 2 diabetes. Am J Physiol Heart Circ Physiol. 2002. 283:H557–H561.
18. Takiuchi S, Fujii H, Kamide K, Horio T, Nakatani S, Hiuge A, Rakugi H, Ogihara T, Kawano Y. Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients. Am J Hypertens. 2004. 17:802–808.
19. Graiser WF, Posch K, Eleonore F, Wascher TC, Kostner GM. Increased superoxide anion formation in endothelial cells during hyperglycemia: an adaptive response or initial step of vascular dysfunction? Diabetes Res Clin Pract. 1999. 45:153–160.
20. Martens FM, Rabelink TJ, op 't Roodt J, de Koning EJ, Visseren FL. TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone. Eur Heart J. 2006. 27:1605–1609.
21. Witte DR, Westerink J, de Koning EJ, van der Graaf Y, Grobbee DE, Bots ML. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? J Am Coll Cardiol. 2005. 45:1987–1993.
22. Chan L, Shaw AG, Busfield F, Haluska B, Barnett A, Kesting J, Short L, Marczak M, Shaw JT. Carotid artery intimal medial thickness, brachial artery flow-mediated vasodilation and cardiovascular risk factors in diabetic and non-diabetic indigenous Australians. Atherosclerosis. 2005. 180:319–326.
23. Jawa A, Nachimuthu S, Pendergrass M, Asnani S, Fonseca V. Impaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensin-converting enzyme inhibitor therapy. J Clin Endocrinol Metab. 2006. 91:31–35.
24. Chan WB, Chan NN, Lai CW, So WY, Lo MK, Lee KF, Chow CC, Metreweli C, Chan JC. Vascular defect beyond the endothelium in type II diabetic patients with overt nephropathy and moderate renal insufficiency. Kidney Int. 2006. 70:711–716.
25. Stehouwer CD, Henry RM, Dekker JM, Nijpels G, Heine RJ, Bouter LM. Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes. Kidney Int Suppl. 2004. 92:S42–S44.
26. Papaioannou GI, Seip RL, Grey NJ, Katten D, Taylor A, Inzucchi SE, Young LH, Chyun DA, Davey JA, Wackers FJ, Iskandrian AE, Ratner RE, Robinson EC, Carolan S, Engel S, Heller GV. Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study). Am J Cardiol. 2004. 08. 01. 94(3):294–299.
28. Furumoto T, Saito N, Dong J, Mikami T, Fujii S, Kitabatake A. Association of cardiovascular risk factors and endothelial dysfunction in japanese hypertensive patients; implications for early atherosclerosis. Furumoto Hypertens Res. 2002. 25:475–480.
29. Lundman P, Eriksson MJ, Stühlinger M, Cooke JP, Hamsten A, Tornvall P. Mild-to-moderate hypertriglycemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am coll Cardiol. 2001. 38:111.
30. Al Suwaidi J, Higano ST, Holmes DR Jr, Lennon R, Lerman A. Obsesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol. 2001. 37:1523.
31. Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S, Matthaei S, Rett K, Häring HU. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation. 2000. 101:1780–1784.
32. Clarkson P, Celermajer DS, Powe AJ, Donald AE, Henry RM, Deanfield JE. Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation. 1997. 96:3378.
33. Lee RT, Kamm RD. Vascular mechanics for the cardiologist. J Am Coll cardiol. 1994. 23:1289–1295.
34. Gibbon GH, Dzau VJ. The emerging concept of vascular remodeling. New Engl J Med. 1994. 330:1431–1438.
35. Enderle M, Benda N, Schmuelling R, Haering HU, Pfohl M. Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects. Diabetes Care. 1998. 21:271–277.
36. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Rand WM, Udelson JE, Karas RH. Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol. 2001. 38:1843–1849.
TOOLS
Similar articles